Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannelore Schmidt

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Gene Therapy|January 24, 2004
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53Matthias Kappler, Matthias Bache, Frank Bartel, et al.
Anticancer Research|August 10, 2002
High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patientsThomas Köhler, Peter Würl, Axel Meye, et al.
Angewandte Chemie (International Ed. in English)|December 6, 2025
Water-Splitting "Without Water": Splitting of the Crystallised Water of Hydrated SaltsKlara Rüwe, Shirui Wang, Tom Bookholt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survivalMatthias Kappler, Matthias Kotzsch, Frank Bartel, et al.
Oncogene|April 28, 2005
Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patientsHelge Taubert, Matthias Kappler, Matthias Bache, et al.
International Journal of Molecular Medicine|May 13, 2004
Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinomaChristian Hoefling, Hannelore Schmidt, Matthias Meinhardt, et al.
Molecular Cancer Research : MCR|October 17, 2008
Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomasHelge Taubert, Frank Bartel, Thomas Greither, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stagesHelge Taubert, Katja Schuster, Ulrich Brinck, et al.
Cancer|April 25, 2003
Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patientsHelge W Taubert, Frank Bartel, Matthias Kappler, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Gene Therapy|January 24, 2004
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53Matthias Kappler, Matthias Bache, Frank Bartel, et al.
Anticancer Research|August 10, 2002
High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patientsThomas Köhler, Peter Würl, Axel Meye, et al.
Angewandte Chemie (International Ed. in English)|December 6, 2025
Water-Splitting "Without Water": Splitting of the Crystallised Water of Hydrated SaltsKlara Rüwe, Shirui Wang, Tom Bookholt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survivalMatthias Kappler, Matthias Kotzsch, Frank Bartel, et al.
Oncogene|April 28, 2005
Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patientsHelge Taubert, Matthias Kappler, Matthias Bache, et al.
International Journal of Molecular Medicine|May 13, 2004
Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinomaChristian Hoefling, Hannelore Schmidt, Matthias Meinhardt, et al.
Molecular Cancer Research : MCR|October 17, 2008
Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomasHelge Taubert, Frank Bartel, Thomas Greither, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stagesHelge Taubert, Katja Schuster, Ulrich Brinck, et al.
Cancer|April 25, 2003
Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patientsHelge W Taubert, Frank Bartel, Matthias Kappler, et al.
Pageof 2